Article
[Diagnosis of Hereditary Tumors Using Multi Gene Panel Testing(MGPT)-Current Status and Issues in Japan or Worldwide].
Gan to kagaku ryoho. Cancer & chemotherapy - 1 Jul 2024
Hirasawa Akira
Abstract excerpt
Pathogenic variant carriers of hereditary tumors have the risk of developing cancer in multiple organs, and genetic testing can be used as an opportunity to conduct surveillance for early detection of cancer and to prevent the development of new cancers and it becomes possible to develop individualized preventive strategies including risk-reductive surgery. Multi gene panel testing(MGPT), which simultaneously...
Topics
Join the communities discussing this publication.
